September 26, 2023
STAND UP TO CANCER AWARDS SEVEN ORGANIZATIONS WITH GRANTS TO INCREASE DIVERSITY IN EARLY-PHASE CANCER CLINICAL TRIALS
Stand Up To Cancer® (SU2C) recently awarded seven community organizations with grants to fund efforts to increase diversity in early phase cancer clinical trials.
Read MoreAugust 21, 2023
STAND UP TO CANCER CELEBRATES MORE THAN $795 MILLION PLEDGED OVER 15 YEARS OF IMPACT
Celebrities, Cancer Survivors and Renowned Scientists Joined Forces for SU2C’s Eighth Roadblock Televised Fundraising Special To Support Critical Cancer Research
Read MoreAugust 15, 2023
PRESIDENT BIDEN AND FIRST LADY JILL BIDEN TO APPEAR ON STAND UP TO CANCER TELEVISED SPECIAL ON AUGUST 19
The President and First Lady will speak to important initiatives currently underway through the Biden Cancer Moonshot to create groundbreaking advancements in cancer research.
Read MoreAugust 6, 2023
STAND UP TO CANCER RETURNS ON AUGUST 19, 2023 FOR EIGHTH ROADBLOCK TELEVISED FUNDRAISING SPECIAL COMMEMORATING 15 YEARS OF IMPACT
The one-hour show will feature a new format and showcase Stand Up To Cancer’s enduring impact at the forefront of innovative and life-saving cancer research
Read MoreJuly 10, 2023
Stand Up To Cancer Names Julian Adams, Ph.D., Chief Science Officer
Veteran Oncology Researcher to Guide Investment in Breakthrough Cancer Treatments
Read MoreJune 1, 2023
Stand Up To Cancer Announces $1.5 Million Commitment From Pancreatic Cancer North America To Fund Pancreatic Cancer Vaccine Research
Stand Up To Cancer® (SU2C) and Pancreatic Cancer North America (PCNA) today announced that PCNA will contribute $1.5 million to SU2C in support of critically needed research focused on pancreatic cancer, which has the highest mortality rate of all major cancers.
Read MoreMay 16, 2023
Will.i.am and George Lopez Join Stand Up To Cancer And Providence In PSA to Increase Awareness of Colorectal Cancer Screening
Grammy®-winning musician will.i.am and stand-up comedian and actor George Lopez have joined Stand Up To Cancer® (SU2C) and Providence for a new series of public service announcements (PSAs) that raise awareness about colorectal cancer screenings, early detection and prevention, and focus on reaching medically underserved communities.
Read MoreApril 11, 2023
Stand Up To Cancer Launches Broadcast PSA To Raise Awareness and Donations for Groundbreaking Cancer Research
The nationally broadcast PSA, It’s All In The Why”, features leading SU2C scientific leadership and funded researchers who speak to the motivation and inspiration behind their work and their shared goal to have a positive impact on people affected by cancer.
Read MoreFebruary 8, 2023
Stand Up To Cancer Announces Four Teams Focused On Diversity In Early Phase Cancer Clinical Trials
Four Multidisciplinary Teams From Chicago, Dallas, Los Angeles and Philadelphia Will Aim To Remove Barriers to Cancer Clinical Trial Participation, With a Focus on Medically Underserved Communities
Read MoreNovember 14, 2022
Stand Up To Cancer Launches New Radio PSA With Jazz Pharmaceuticals To Encourage Lung Cancer Screening
Jazz PSA aims to raise awareness in Black and Hispanic communities about small cell lung cancer and encourage listeners to learn about screening options.
Read More